Spravato® Treatment
in Olathe, KS
Neowellnez offers a path forward for adults in Olathe, KS, who have not found relief with traditional antidepressants. Spravato® is an innovative, FDA-approved esketamine nasal spray administered in our structured, supportive environment to help manage persistent depression. Our goal is to provide a renewed sense of well-being and help you navigate your journey toward mental wellness with compassionate, tailored care.
What Is Spravato® Therapy in Olathe, KS?
FDA-Approved for TRD
Spravato® is specifically approved for treatment-resistant depression (TRD). This makes it a valuable option for individuals who have tried at least two oral antidepressants without achieving significant improvement in their symptoms.
Medically Supervised Administration
For your safety, every treatment is administered in our certified healthcare setting. Patients self-administer the nasal spray under the direct observation of a healthcare provider who is present throughout the session.
Targeted Brain Pathway
Unlike many antidepressants that work on serotonin or norepinephrine, Spravato® targets the brain’s glutamate system. This different pathway can be effective when other medications have not provided adequate relief.
Structured Treatment Schedule
Spravato® therapy is delivered on a structured induction and maintenance schedule. The protocol is designed to safely maximize therapeutic benefits, with visit frequency adjusting over time based on your clinical response.
Paired with an Oral Antidepressant
Spravato® is not a standalone treatment; it is prescribed for use in conjunction with an ongoing oral antidepressant. This combination approach is designed to provide comprehensive and sustained symptom management.
REMS Safety Program
Patient safety is paramount. Spravato® is a REMS (Risk Evaluation and Mitigation Strategy) drug, requiring administration and observation in a certified medical office to manage potential side effects like dissociation and sedation.
Comprehensive Care Approach
Successful treatment integrates Spravato® within a comprehensive care plan. At Neowellnez, this includes ongoing psychiatric oversight to manage your overall treatment strategy, adjust medications, and support your long-term mental health.
Why Choose Our Compassionate Care?
Our team at Neowellnez provides thoughtful, structured care centered around your safety and well-being. We dedicate time to understanding your history and create a manageable treatment plan. Our Care Navigators are available to guide you through eligibility, scheduling, and every step of the process, ensuring you feel supported from your very first call.
Our Spravato® Therapy Process
Initial Eligibility Assessment
Your journey begins with a comprehensive psychiatric evaluation. We will review your mental health history, previous medication trials, and current symptoms to determine if Spravato® is an appropriate and safe option for you.
Your First Treatment Session
On your first treatment day, we’ll guide you through the process in a private, comfortable room. After a brief check-in, you will self-administer the Spravato® nasal spray under the supervision of our clinical staff.
In-Office Monitoring Period
Following administration, you will rest in our office for a monitoring period of approximately two hours. Our team will observe you for any immediate side effects like dizziness or changes in blood pressure, ensuring your comfort and safety.
Induction and Stabilization Phases
The initial phase of treatment typically involves two sessions per week for the first four weeks. This is followed by a stabilization phase of one session per week as we assess your response and progress toward your goals.
Maintenance and Ongoing Care
After the initial phases, treatment frequency is adjusted based on your individual needs, often to every other week. We collaborate with you to develop a long-term maintenance plan that sustains your improvement.
Who Benefits from Spravato® Therapy?
Neowellnez offers a path forward for adults in Olathe, KS, who have not found relief with traditional antidepressants. Spravato® is an innovative, FDA-approved esketamine nasal spray administered in our structured, supportive environment to help manage persistent depression. Our goal is to provide a renewed sense of well-being and help you navigate your journey toward mental wellness with compassionate, tailored care.
Conditions We Treat
- Treatment-Resistant Depression (TRD)
- Persistent Sadness or Low Mood
- Loss of Interest in Daily Activities
- Limited Response to Prior Medications
- Persistent Feelings of Hopelessness
Cost of Spravato® Therapy in Olathe, KS
Neowellnez offers a path forward for adults in Olathe, KS, who have not found relief with traditional antidepressants. Spravato® is an innovative, FDA-approved esketamine nasal spray administered in our structured, supportive environment to help manage persistent depression. Our goal is to provide a renewed sense of well-being and help you navigate your journey toward mental wellness with compassionate, tailored care.
FAQ About Spravato® Therapy in Olathe, KS
How is Spravato® different from traditional antidepressants?
Spravato® works on the brain’s glutamate system, a different pathway than most oral antidepressants that target serotonin. This unique mechanism of action makes it a viable option for individuals who haven’t responded to at least two other antidepressant medications.
What happens during a Spravato® treatment session?
A session involves self-administering the nasal spray under our supervision, followed by a quiet, two-hour monitoring period in our office. You will need to arrange for a ride home afterwards and should not drive or make major decisions until the next day.
Is Spravato® therapy covered by insurance?
Many insurance plans, including Medicare, offer coverage for Spravato® when it is deemed medically necessary for treatment-resistant depression. Our team will assist you with benefits verification and understanding any out-of-pocket costs, such as co-pays or deductibles.
How long does the full course of treatment take?
The initial induction phase is typically twice a week for four weeks, then weekly for another four weeks. After that, treatment frequency is adjusted to a maintenance schedule, such as once weekly or every other week, based on your clinical response.
The Right Care Can
Change Everything
confidence, and hope.
